Lin Zheng, Wu Yang, Wen-ying Xiang, Jia Sun, Si-ying Chen, Yong-jun Li
{"title":"[Simultaneous Determination of Protocatechuic Acid,Kaempferol Biotin Glucoside and Quercitrin in Rat Plasma and Pharmacokinetics By UPLC-MS/MS].","authors":"Lin Zheng, Wu Yang, Wen-ying Xiang, Jia Sun, Si-ying Chen, Yong-jun Li","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To develop a sensitive and reliable ultra performance liquid chromatography tandem mass spectrometry ( UPLC-MS / MS) method for simultaneous determination and pharmacokinetics of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, and study their pharmacokinetic characteristics in rats.</p><p><strong>Methods: </strong>Three compounds were simultaneously determined by UPLC-MS / MS on Waters BEH C18( 50 mm × 2. 1 mm,1. 7 μm) column. The mobile phase was 0. 1% acetonitrile formic acid and0. 1% aqueous formic acid, and programmed in a linear gradient mode. The compounds were ionized in the electrospray ionization ion source of the mass spectrometer and detected in MRM mode.</p><p><strong>Results: </strong>The t1 /2of protocatechuic acid,kaempferol biotin glucoside and quercitrin after intravenous injection were( 41. 9 ± 12. 3),( 71. 3 ± 56. 8) and( 90. 3 ± 74. 8) min. The Cmaxwere( 1. 7 ± 0. 7) μg / m L,( 2. 1 ± 0. 9) μg/m L,( 8. 7 ± 3. 7) μg/m L.</p><p><strong>Conclusion: </strong>The established method is specific,rapid,accurate and sensitive,and is proved to meet the requirements of biological sample analyses,and is suitable for the concentration determination of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, three compounds are all best fitted to the two-compartment open pharmacokinetic model.</p>","PeriodicalId":15312,"journal":{"name":"中药材","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中药材","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To develop a sensitive and reliable ultra performance liquid chromatography tandem mass spectrometry ( UPLC-MS / MS) method for simultaneous determination and pharmacokinetics of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, and study their pharmacokinetic characteristics in rats.
Methods: Three compounds were simultaneously determined by UPLC-MS / MS on Waters BEH C18( 50 mm × 2. 1 mm,1. 7 μm) column. The mobile phase was 0. 1% acetonitrile formic acid and0. 1% aqueous formic acid, and programmed in a linear gradient mode. The compounds were ionized in the electrospray ionization ion source of the mass spectrometer and detected in MRM mode.
Results: The t1 /2of protocatechuic acid,kaempferol biotin glucoside and quercitrin after intravenous injection were( 41. 9 ± 12. 3),( 71. 3 ± 56. 8) and( 90. 3 ± 74. 8) min. The Cmaxwere( 1. 7 ± 0. 7) μg / m L,( 2. 1 ± 0. 9) μg/m L,( 8. 7 ± 3. 7) μg/m L.
Conclusion: The established method is specific,rapid,accurate and sensitive,and is proved to meet the requirements of biological sample analyses,and is suitable for the concentration determination of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, three compounds are all best fitted to the two-compartment open pharmacokinetic model.
期刊介绍:
"Chinese Materia Medica" magazine was founded in 1978. It is a national-level academic journal of Chinese medicine science and technology approved by the State Science and Technology Commission and the Press and Publication Administration for public distribution at home and abroad. It is sponsored by the Chinese Materia Medica Information Center of the State Food and Drug Administration and is publicly distributed at home and abroad. It mainly reports on new technologies, new methods and new achievements in the production, scientific research and business management of Chinese medicine, and serves to promote the production and scientific and technological development of Chinese medicine, improve the output and quality of Chinese medicine, improve business management, and prosper the Chinese medicine industry.